Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio.
Leukemia. 2017 Jan;31(1):26-33. doi: 10.1038/leu.2016.183. Epub 2016 Jun 24.
Leukemia. 2017.
PMID: 27416910
Free article.
High expression of transcription factor 4 (TCF4) is an independent adverse prognostic factor in acute myeloid leukemia that could guide treatment decisions.
in 't Hout FE, van der Reijden BA, Monteferrario D, Jansen JH, Huls G.
in 't Hout FE, et al.
Haematologica. 2014 Dec;99(12):e257-9. doi: 10.3324/haematol.2014.110437. Epub 2014 Aug 22.
Haematologica. 2014.
PMID: 25150259
Free PMC article.
No abstract available.
Item in Clipboard
TCF4 promotes erythroid development.
In 't Hout FEM, van Duren J, Monteferrario D, Brinkhuis E, Mariani N, Westers TM, Chitu D, Nikoloski G, van de Loosdrecht AA, van der Reijden BA, Jansen JH, Huls G.
In 't Hout FEM, et al.
Exp Hematol. 2019 Jan;69:17-21.e1. doi: 10.1016/j.exphem.2018.10.002. Epub 2018 Oct 10.
Exp Hematol. 2019.
PMID: 30315825
Free article.
Item in Clipboard
Transcription factor 4 (TCF4) expression predicts clinical outcome in RUNX1 mutated and translocated acute myeloid leukemia.
In't Hout FEM, Gerritsen M, Bullinger L, Van der Reijden BA, Huls G, Vellenga E, Jansen JH.
In't Hout FEM, et al.
Haematologica. 2020 Sep 1;105(9):e454-457. doi: 10.3324/haematol.2019.232827.
Haematologica. 2020.
PMID: 33054062
Free PMC article.
No abstract available.
Item in Clipboard
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial.
van de Loosdrecht AA, Cremers EMP, Alhan C, Duetz C, In 't Hout FEM, Visser-Wisselaar HA, Chitu DA, Verbrugge A, Cunha SM, Ossenkoppele GJ, Janssen JJWM, Klein SK, Vellenga E, Huls GA, Muus P, Langemeijer SMC, de Greef GE, Te Boekhorst PAW, Raaijmakers MHG, van Marwijk Kooy M, Legdeur MC, Wegman JJ, Deenik W, de Weerdt O, van Maanen-Lamme TM, Jobse P, van Kampen RJW, Beeker A, Wijermans PW, Biemond BJ, Tanis BC, van Esser JWJ, Schaar CG, Noordzij-Nooteboom HS, Jacobs EMG, de Graaf AO, Jongen-Lavrencic M, Stevens-Kroef MJPL, Westers TM, Jansen JH.
van de Loosdrecht AA, et al. Among authors: in t hout fem.
Leukemia. 2024 Apr;38(4):840-850. doi: 10.1038/s41375-024-02161-6. Epub 2024 Jan 31.
Leukemia. 2024.
PMID: 38297135
Free PMC article.
Clinical Trial.
Item in Clipboard
Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma.
In 't Hout FE, Haydu LE, Murali R, Bonenkamp JJ, Thompson JF, Scolyer RA.
In 't Hout FE, et al.
Ann Surg. 2012 Jun;255(6):1165-70. doi: 10.1097/SLA.0b013e31824c4b0b.
Ann Surg. 2012.
PMID: 22566014
Item in Clipboard
Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)-mutant myelodysplastic syndromes subtype.
Duetz C, Westers TM, In 't Hout FEM, Cremers EMP, Alhan C, Venniker-Punt B, Visser-Wisselaar HA, Chitu DA, de Graaf AO, Smit L, Jansen JH, van de Loosdrecht AA.
Duetz C, et al. Among authors: in t hout fem.
Br J Haematol. 2021 May;193(4):798-803. doi: 10.1111/bjh.17414. Epub 2021 Mar 25.
Br J Haematol. 2021.
PMID: 33765355
Free PMC article.
Clinical Trial.
Item in Clipboard
[Medicinal cannabis].
van den Elsen GAH, In 't Hout FEM, de Vries M, Olde Rikkert MGM, Kramers C, Verkes RJ.
van den Elsen GAH, et al. Among authors: in t hout fem.
Ned Tijdschr Geneeskd. 2019 May 3;163:D3629.
Ned Tijdschr Geneeskd. 2019.
PMID: 31120212
Review.
Dutch.
Item in Clipboard
Cite
Cite